Abstract: A Chrysanthemum zawadskii (abbrev. to “Chrysanthemum”) extract with adjusted contents of each of indicator components of Chrysanthemum zawadskii (abbrev. to “Chrysanthemum”) is disclosed. The indicator components include linarin, chlorogenic acid and isochlorogenic acid. Also disclosed is a method for setting a standard for contents of the indicator components by identifying causes of the difference in properties of the Chrysanthemum extract or raw material and standardizing a preparation process from the analyzed causes of the difference in properties, to obtain a Chrysanthemum extract standardized by setting a content range of each indicator component in the Chrysanthemum raw material. Uses of the extract or a composition containing the extract are disclosed.

Abstract: A functional food composition contains a Lonicera japonica extract as an active ingredient is disclosed. The functional food composition is useful in alleviating irritable bowel syndrome. The Lonicera japonica extract reduces diarrhea and/or intestinal intonation symptoms, thereby exhibiting an effect of alleviating irritable bowel syndrome. A method of treating or alleviating irritable bowel syndrome includes a step of administering a composition to a subject, wherein the composition contains a Lonicera japonica extract.

Abstract: Disclosed herein is a cell therapeutic composition for treating ischemic limb diseases, more specifically, disclosed is a cell therapeutic composition for treating ischemic diseases, which contains adipose tissue-derived mesenchymal stem cells and sucrose or mannose as an excipient. The composition induces angiogenesis around closed blood vessels in the ischemic limb lesions, and thus is useful to treat ischemic diseases.

Abstract: The present invention relates to an improved acid disinfectant composition which exhibits excellent bactericidal activity against a wide spectrum of Gram-negative and Gram-positive bacteria.